Carl L. Scheckel
Impact in
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Pharmacology top 10%
- Cannabis and Cannabinoid Research
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Neuroscience and Neuropharmacology Research 5
- Neurotransmitter Receptor Influence on Behavior 4
-
- Pharmacogenetics and Drug Metabolism 2
- Alkaloids: synthesis and pharmacology 1
Carl L. Scheckel
12 papers receiving 297 citations
Peers
Comparison fields: 5 of 44
- Cellular and Molecular Neuroscience 152
- Pharmacology 124
- Biological Psychiatry 4
- Anesthesiology and Pain Medicine 20
- Pharmacology 27
Countries citing papers authored by Carl L. Scheckel
This map shows the geographic impact of Carl L. Scheckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl L. Scheckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl L. Scheckel more than expected).
Fields of papers citing papers by Carl L. Scheckel
This network shows the impact of papers produced by Carl L. Scheckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl L. Scheckel. The network helps show where Carl L. Scheckel may publish in the future.
Co-authors
The 11 scholars most cited alongside Carl L. Scheckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1968 | 106 | |
| 2 | 1964 | 89 | |
| 3 | Pharmacology of the metabolites of chlordiazepoxide and diazepam. | 1965 | 71 |
| 4 | 1969 | 33 | |
| 5 | 1965 | 25 | |
| 6 | Pharmacological studies on flurazepam hydrochloride (RO 5-6901), a new psychotropic agent of the benzodiazepine class. | 1969 | 17 |
| 7 | Pharmacology of medazepam and metabolites. | 1970 | 17 |
| 8 | [ON THE PHARMACOLOGY OF MOGADON, A HYPNOTIC WITH AN UNUSUAL ACTION MECHANISM]. | 1965 | 16 |
| 9 | [On the pharmacology of Valium, a new psychopharmacologic agent on the benzodiazepine series]. | 1963 | 9 |
| 10 | BEHAVIORAL STIMULATION IN RATS ASSOCIATED WITH A SELECTIVE RELEASE OF BRAIN NOREPINEPHRINE. | 1964 | 8 |
| 11 | [On the pharmacology of the new psychoactive drug 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (Ro5-4556)]. | 1968 | 6 |
| 12 | 2015 | 1 |
About Carl L. Scheckel
Carl L. Scheckel is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Anesthesiology and Pain Medicine, Psychiatry and Mental health and Organic Chemistry, having authored 12 papers that have together received 398 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Anesthesia and Sedative Agents (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Alkaloids: synthesis and pharmacology (1 paper), Neural and Behavioral Psychology Studies (1 paper) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (152 citations), Pharmacology (124 citations), Biological Psychiatry (4 citations), Anesthesiology and Pain Medicine (20 citations) and Pharmacology (27 citations). Frequent co-authors include Edward Boff, L O RANDALL, R Banziger, W F Pool, William Schallek, Lowell O. Randall, Robert E. Bagdon, Paul L. Stefko, A. Boris and G. Zbinden. Their work appears in journals such as Psychopharmacology, Science, Annals of the New York Academy of Sciences, Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.